Tuesday morning, 9:47 AM. The Series B is two quarters out. The science is strong. The investor narrative still reads like a research abstract. The board wants commercial-traction proof, not paper proof.
Berkeley operators ship from research. The science is the foundation. Commercial translation is a different function and most teams underbuild it.
By 10:22 the founder asks the question. How do we make the commercial motion legible to a Series B investor without losing the scientific credibility we have spent five years building.
Commercial credibility and scientific credibility are different muscles. Both need to be in writing.
Biotech, edtech, and climate-tech operators in Berkeley face this most acutely. The product is in development; the buyer recognition needs to compound before the product ships.
The Positioning Sprint translates research-led capability into commercial narrative. 14 business days. $7,500 flat. Output covers category narrative, ICP architecture, sales motion definition, and 90-day execution plan.
For Berkeley research-led operators, the Strategy Diagnostic at $5,000 also covers the four-axis architecture in 10 days. The Diagnostic fits when commercial strategy is the primary gap.
Both engagements respect the science. The diagnostic does not water down the technical narrative; it produces the parallel commercial narrative the team needs for board, fundraise, and partnership conversations.
Yes. Research-led operators (biotech, edtech, climate tech) face common patterns: scientific credibility must remain intact while commercial credibility is built in parallel. The diagnostic handles both registers.
Yes. Berkeley signals research-grade operating altitude. Global pharma and enterprise read it as production-grade scientific credibility. Geography is bonus signal.
Scientific PR amplifies the science. The diagnostic builds the commercial frame around it. Different jobs, different formats, often used together. The diagnostic produces the brief PR works against.
Strategy Diagnostic $5,000. Positioning Sprint $7,500. Paid Media Audit $2,500. Conversion Review $3,500. Marketing Partnership $4,500/month. AI Visibility Audit $2,500.
Most Berkeley agencies sell either scientific PR or generic SaaS marketing. The diagnostic produces the commercial-strategy document research-led teams need but rarely have in writing.
Yes. Pre-launch positioning is one of the highest-leverage moments. NDA signed before any work begins. Confidentiality is a default for research-led operators.
Four-axis commercial strategy for research-led operators.
Read the gate →Category narrative bridging scientific and commercial credibility.
Read the gate →Answer-engine query coverage for research-led category claims.
Read the gate →Anonymized case template. Industry, stage, scope, 90-day result framing. To be filled when client cases are approved for publication.
Anonymized case template. Industry, stage, scope, 90-day result framing. To be filled when client cases are approved for publication.
Anonymized case template. Industry, stage, scope, 90-day result framing. To be filled when client cases are approved for publication.
Scientific credibility is the foundation. Commercial narrative is the leverage.
Start with the Strategy Diagnostic · $5,000 →